/ Not yet recruitingPhase 1 注射用HYC11395在健康人体的耐受性及药代动力学低剂量探索研究
[Translation] Low-dose exploratory study on the tolerability and pharmacokinetics of HYC11395 for injection in healthy humans
探索单次静脉给予低剂量注射用HYC11395在中国健康志愿者体内的耐受性和药代动力学特征,为制定后续临床试验给药方案提供依据。
[Translation] To explore the tolerability and pharmacokinetic characteristics of a single intravenous low-dose injection of HYC11395 in healthy Chinese volunteers, and provide a basis for formulating dosing regimens for subsequent clinical trials.
100 Clinical Results associated with Nanjing Heqi Pharmaceutical Technology Co Ltd
0 Patents (Medical) associated with Nanjing Heqi Pharmaceutical Technology Co Ltd
100 Deals associated with Nanjing Heqi Pharmaceutical Technology Co Ltd
100 Translational Medicine associated with Nanjing Heqi Pharmaceutical Technology Co Ltd